arginine has been researched along with Neuroblastoma in 89 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (23.60) | 18.7374 |
| 1990's | 36 (40.45) | 18.2507 |
| 2000's | 10 (11.24) | 29.6817 |
| 2010's | 17 (19.10) | 24.3611 |
| 2020's | 5 (5.62) | 2.80 |
| Authors | Studies |
|---|---|
| Aburatani, H; Fujii, Y; Hata, K; Hiwatari, M; Isobe, T; Kato, M; Kawai, T; Kimura, S; Koh, K; Kubota, Y; Miyano, S; Nagae, G; Nannya, Y; Ogawa, S; Oka, A; Sato, Y; Sato-Otsubo, A; Seki, M; Sekiguchi, M; Suzuki, H; Takita, J; Tanaka, H; Ueno, H; Watanabe, K; Yoshida, K | 1 |
| Aggarwal, N; Chauhan, VS; Kour, A; Kumar, A; Panda, JJ; Sekhar Panda, H; Shukla, S; Tiwari, S; Tiwari, V | 1 |
| Cheng, W; Du, B; Li, L; Yang, J; Yu, Z; Zhang, F; Zhang, W; Zhang, X; Zhou, C; Zhou, Q | 1 |
| Booth, S; Chesler, L; De Santo, C; Dunn, WB; Fultang, L; Jankevics, A; Lee, SP; Lloyd, G; Martins da Costa, B; Mussai, F; Panetti, S; Scarpa, U; Southam, A; Stavrou, V; Tubb, V; Yogev, O | 1 |
| Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y | 1 |
| Dedhe, A; Hansen, JN; Li, X; Lotta, LT; Schor, NF; Zheng, YG | 1 |
| Ghosh, D; Jha, NN; Kumar, A; Kumar, R; Maji, SK; Mehra, S; Navalkar, A; Padinhateeri, R; Panigrahi, R; Ranganathan, S | 1 |
| Berry, AM; Booth, S; Brownhill, S; Burchill, SA; Cheng, PN; Chesler, L; De Bie, F; De Santo, C; Eden, GL; Egan, SA; Etchevers, HC; Fultang, L; Gamble, LD; Gneo, L; Haber, M; McConville, CM; Murray, J; Mussai, F; Norris, MD; Schmidt, R; Vardon, A; Yogev, O; Ziegler, DS | 1 |
| Closs, EI; Habermeier, A; Karbach, S; Simon, A | 1 |
| Patel, RC; Snee, B; Vaughn, LS | 1 |
| Baillie, GS; Cairns, LS; Cameron, RT; Carlos Penedo, J; MacLeod, R; Quinn, SD; Samuel, ID; Smith, BO | 1 |
| Anderson, J; Bendle, G; Chesler, L; De Santo, C; Egan, S; Fisher, J; Hunter, S; McConville, C; Mussai, F; Petrie, K; Sbirkov, Y; Webber, H; Wheat, R; Wheeler, K | 1 |
| Eberhardt, A; Hansen, JN; Koster, J; Li, X; Livingstone, E; Lotta, LT; Qian, K; Schor, NF; Valentijn, LJ; Wang, S; Zheng, YG | 1 |
| Harris, B; Parkin, E | 1 |
| Haber, M; Iismaa, SE; Liu, PY; Liu, T; Marshall, GM; Norris, MD; Tee, AEL; Xu, N | 1 |
| Hall, WW; Kimura, T; Nagashima, K; Okada, Y; Orba, Y; Sawa, H; Sunden, Y; Suzuki, T; Tanaka, S | 1 |
| Abe, K; Everhart, L; Jönsson-Rylander, AC; Kitlinska, J; Kuan-Celarier, A; Kuo, L; Li, L; Lu, C; Munivenkatappa, RB; Sun, CC; Sun, J; Tilan, J; Toretsky, JA; Zukowska, Z | 1 |
| Brouwers, N; Funamoto, S; Ihara, Y; Iwata, N; Matsuba, Y; Mihira, N; Nilsson, P; Nishimura, M; Saido, TC; Saito, T; Sleegers, K; Suemoto, T; Takano, J; Van Broeckhoven, C; Yamada, K | 1 |
| Bernhardt, G; Buschauer, A; Keller, M | 1 |
| Chabeauti, PY; Chalon, S; Decressac, M; Frangeul, L; Gaillard, A; Herzog, H; Jaber, M; Pain, S; Thiriet, N; Vergote, J | 1 |
| Amati-Bonneau, P; Barth, M; Bonneau, D; Chevrollier, A; Desquiret-Dumas, V; Gueguen, N; Hancock, S; Henrion, D; Procaccio, V; Reynier, P; Wallace, DC | 1 |
| Chen, X; Cui, L; Guan, T; Kong, J; Li, C; Li, XM; Shang, H; Zhang, X | 1 |
| Biswas, KK; Hashiguchi, T; Lee, KY; Maruyama, I; Sarker, KP; Yamaji, K; Yamakuchi, M | 1 |
| Altermann, WW; Erhuma, ME; Foell, J; Schlaf, G; Seliger, B | 1 |
| Bammler, TK; Hashioka, S; Jin, J; Kashima, DT; Klegeris, A; Li, J; Maguire, J; McGeer, PL; Pan, S; Zhang, J; Zhu, D | 1 |
| Deguchi, T; Yoshioka, M | 1 |
| Richelson, E; Snider, RM | 1 |
| Kozlowski, KA; Schultz, RM; Wezeman, FH | 1 |
| Cano, E; Doyle, J; Fresno, M; Liew, FY; Muñoz-Fernández, MA; O'Donnell, CA | 1 |
| Enami, T; Hoson, M; Kashimura, T; Kawada, T; Mochizuki, A; Nakada, K; Wakisaka, M; Yamate, N | 1 |
| el-Fakahany, EE; Hu, J; Lee, JH | 1 |
| Doods, HN; Eberlein, W; Engel, W; Entzeroth, M; Rudolf, K; Wieland, HA; Wienen, W; Willim, KD | 1 |
| Braunger, H; Doods, HN; Eberlein, W; Engel, W; Entzeroth, M; Rudolf, K; Wieland, HA; Wienen, W; Willim, KD | 1 |
| Corasaniti, MT; Finazzi-Agrò, A; Melino, G; Nisticò, G; Tartaglia, RL | 2 |
| Asai, M; Kanba, S; Kato, R; Nakaki, T; Nakamura, R; Richelson, E; Sato, K; Shintani, F; Yagi, G | 1 |
| el-Fakahany, EE; Hu, J | 1 |
| Corasaniti, MT; Finazzi-Agrò, A; Garaci, E; Melino, G; Navarra, M; Nisticò, G | 1 |
| Blumenthal, KM; Dias-Kadambi, BL; Drum, CL; Hanck, DA | 1 |
| Liu, PS; Shaw, YH | 1 |
| Cuadra, AE; El-Fakahany, EE | 1 |
| Goto, S; Komatsu, K; Kondo, T; Matsuda, I; Ogura, T; Sumikawa, K; Todoroki, S; Urata, Y | 1 |
| Alling, C; Caron, MH | 1 |
| Daly, JM; Lieberman, MD; Nishioka, K; Redmond, HP | 1 |
| el-Fakahany, EE; Pou, S; Pou, WS; Rosen, GM | 2 |
| Arroyo, CM; Forray, C | 1 |
| Deguchi, T; Fujimori, H; Inamura, K; Ishikawa, F; Kosasayama, A; Masayasu, H; Suzuki, K; Yoshioka, M | 1 |
| Arroyo, CM; el-Fakahany, EE; Forray, C; Rosen, GM | 1 |
| Förstermann, U; Gorsky, LD; Ishii, K; Murad, F | 2 |
| Bolden, C; Johnson, A; McKinney, M; Richelson, E; Smith, C | 1 |
| Daly, JM; Naji, A; Reynolds, JV; Shou, J; Sigal, R; Ziegler, MM | 1 |
| Daly, JM; Naji, A; Reynolds, JV; Thom, AK; Zhang, SM; Ziegler, MM | 1 |
| Nascimento, FA; Nery, J; Pianovski, MA; Trennepohl, J | 1 |
| Waltereit, R; Weller, M | 1 |
| Hirschfeld, S; Ho, PT; Pazdur, R; Smith, M | 1 |
| Bonetti, F; Boni, L; Bruzzi, P; Carli, M; Conte, M; Cordero Di Montezemolo, L; D'Angelo, P; Dallorso, S; De Bernardi, B; di Cataldo, A; Donfrancesco, A; Gambini, C; Garaventa, A; Indolfi, P; Nicolas, B; Pession, A; Provenzi, M; Rizzo, A; Tonini, GP; Zanazzo, A | 1 |
| Chen, XQ; He, YJ; Lin, TY; Liu, DG; Su, YS; Sun, XF | 1 |
| Alonso, MT; Leyland-Jones, B; Marsoni, S; O'Dwyer, PJ | 1 |
| Pritchard, J; Rogers, DW; Shafford, EA | 1 |
| Casper, J; Cornet, J; Evans, WE; Green, AA; Hayes, FA | 1 |
| Lockwood, L; Mameghan, H; McCowage, GB; Shaw, PJ; Vowels, MR | 1 |
| Pritchard, J | 1 |
| Altshuler, GA; Castleberry, RP; Green, AA; Hayes, FA; McWilliams, NB; Nitschke, R; Shuster, JJ; Smith, EI; Vietti, TJ | 1 |
| Crist, WM; Pratt, CB; Pui, CH; Rivera, GK; Santana, VM | 1 |
| Lam-Po-Tang, PR; McCowage, GB; Vowels, MR | 1 |
| Bernard, JL; Bouffet, E; Coze, C; Frappaz, D; Ladenstein, R; Louis, D; Philip, T; Pinkerton, R; Siegert, W; Zucker, JM | 1 |
| Bowman, LC; Brodeur, GM; Cantor, A; Castleberry, RP; Cohn, SL; Hayes, FA; Joshi, V; Look, AT; Smith, EI; Yu, A | 1 |
| Felix, CA; Lange, BJ; Megonigal, MD; Nowell, PC; Pegram, LD; Rappaport, EF; Rowley, JD | 1 |
| Bleyer, WA; Chard, RL; Hammond, D; Krivit, W | 1 |
| Avery, T; Green, A; Hayes, A; Pratt, C; Rivera, G | 1 |
| Eden, T; Shaw, PJ | 1 |
| Biron, P; Bouffet, E; Brunat-Mentigny, M; Chauvin, F; Ladenstein, R; Lasset, C; Philip, I; Philip, T | 1 |
| Brugieres, L; Giron, A; Habrand, JL; Hartmann, O; Kalifa, C; Lemerle, J; Suarez, A; Valteau, D; Vassal, G | 1 |
| Cheung, NV; Heller, G | 1 |
| Anderson, JR; Coccia, PF | 1 |
| Barnes, JM; Lewis, IJ; Pearson, AD; Pinkerton, CR; Stevens, MC | 1 |
| Carstensen, H; Hertz, H; Nolte, H | 1 |
| Feig, SA; Harris, R; Lenarsky, C; Moss, TJ; Ramsay, N; Reynolds, CP; Sather, H; Seeger, RC; Selch, M; Wells, J | 1 |
| Bowman, A; De Kraker, J; Kellie, SJ; Lilleyman, JS; Pritchard, J | 1 |
| Beaujean, F; Behard, C; Benhamou, E; Deville, A; Flamant, F; Hartmann, O; Kalifa, C; Lejars, O; Patte, C; Thyss, A | 2 |
| Fortner, CL; King, SA; Leyland-Jones, B; O'Dwyer, PJ | 1 |
| Abromowitch, M; Evans, WE; Hayes, FA; Rivera, GK; Rodman, JH; Sinkule, JA | 1 |
| Etoh, T; Kuriyama, Y; Maie, M; Ohnuma, N; Takahashi, H; Tanabe, M | 1 |
| Abromowitch, M; Green, AA; Hayes, FA | 1 |
| Bayle, C; Beaujean, F; Benhamou, E; Hartmann, O; Kalifa, C; Lemerle, J | 1 |
| Hill, BT; Pritchard, J; Whelan, R | 1 |
7 review(s) available for arginine and Neuroblastoma
| Article | Year |
|---|---|
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Using Chemistry to Target Neuroblastoma.
Topics: Animals; Arginine; Humans; Neural Crest; Neuroblastoma; Oncogene Proteins; Reactive Oxygen Species; Signal Transduction | 2017 |
Regulatory approvals of pediatric oncology drugs: previous experience and new initiatives.
Topics: Antineoplastic Agents; Azacitidine; Child; Child, Preschool; Drug Approval; Humans; Leukemia, Myeloid, Acute; Methotrexate; Neuroblastoma; Osteosarcoma; Pediatrics; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide; United States; United States Food and Drug Administration; Vindesine | 2003 |
Teniposide: a review of 12 years of experience.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Cycle; Cell Line; Child; Clinical Trials as Topic; Colonic Neoplasms; DNA, Neoplasm; Drug Evaluation, Preclinical; Drug Resistance; Humans; Leukemia; Lymphoma; Mice; Neoplasms; Neoplasms, Experimental; Neuroblastoma; Podophyllotoxin; Teniposide | 1984 |
Epipodophyllotoxins in the treatment of childhood cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cytarabine; Etoposide; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Neoplasms; Neoplasms, Second Primary; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 1994 |
Neuroblastoma with intracranial involvement: an ENSG Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cisplatin; Cranial Fossa, Posterior; Cyclophosphamide; Europe; Humans; Infant; Male; Neuroblastoma; Prevalence; Registries; Teniposide; Vincristine | 1992 |
Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Humans; Multivariate Analysis; Neoplasm Staging; Neuroblastoma; Retrospective Studies; Survival Rate; Teniposide; Vincristine | 1991 |
7 trial(s) available for arginine and Neuroblastoma
| Article | Year |
|---|---|
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Teniposide: a review of 12 years of experience.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Cycle; Cell Line; Child; Clinical Trials as Topic; Colonic Neoplasms; DNA, Neoplasm; Drug Evaluation, Preclinical; Drug Resistance; Humans; Leukemia; Lymphoma; Mice; Neoplasms; Neoplasms, Experimental; Neuroblastoma; Podophyllotoxin; Teniposide | 1984 |
Cyclophosphamide/doxorubicin vs. cisplatin/teniposide in the treatment of children older than 12 months of age with disseminated neuroblastoma: a Pediatric Oncology Group Randomized Phase II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Humans; Infant; Neoplasm Metastasis; Neuroblastoma; Prognosis; Prospective Studies; Remission Induction; Survival Rate; Teniposide; United States | 1995 |
Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE2 study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Carmustine; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Infant; Male; Melphalan; Neuroblastoma; Pilot Projects; Teniposide; Vincristine | 1993 |
Phase II study of VM-26 in acute leukemia, neuroblastoma, and other refractory childhood malignancies: a report from the Children's Cancer Study Group.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow; Child; Clinical Trials as Topic; Drug Evaluation; Humans; Leukemia; Leukemia, Lymphoid; Neoplasms; Neuroblastoma; Podophyllotoxin; Remission, Spontaneous; Teniposide | 1979 |
A single center experience with bone marrow transplantation for high risk neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Carmustine; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; France; Humans; Infant; Male; Neuroblastoma; Organoplatinum Compounds; Remission Induction; Reoperation; Survival Rate; Teniposide; Vincristine | 1991 |
Carboplatin activity in cisplatin treated neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Audiometry; Bone Marrow; Carboplatin; Child, Preschool; Cisplatin; Cyclophosphamide; Drug Evaluation; Female; Humans; Male; Neoplasm Staging; Neuroblastoma; Teniposide; Vincristine | 1991 |
77 other study(ies) available for arginine and Neuroblastoma
| Article | Year |
|---|---|
Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism.
Topics: Arginine; Cell Line, Tumor; Cell Proliferation; DNA Methylation; Gene Expression Regulation, Neoplastic; Humans; N-Myc Proto-Oncogene Protein; Neuroblastoma; Serine | 2022 |
Anti-amyloidogenic amphipathic arginine-dehydrophenylalanine spheres capped selenium nanoparticles as potent therapeutic moieties for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Arginine; Dipeptides; Humans; Nanoparticles; Neuroblastoma; Peptide Fragments; Phenylalanine; Rats; Selenium; Streptozocin | 2023 |
Joint analysis of the metabolomics and transcriptomics uncovers the dysregulated network and develops the diagnostic model of high-risk neuroblastoma.
Topics: Arginine; Humans; Linoleic Acid; Metabolomics; Neuroblastoma; Transcriptome; Vitamin A | 2023 |
Metabolic engineering against the arginine microenvironment enhances CAR-T cell proliferation and therapeutic activity.
Topics: Animals; Apoptosis; Arginine; Argininosuccinate Synthase; Cell Proliferation; Humans; Immunotherapy, Adoptive; Leukemia, Myeloid, Acute; Metabolic Engineering; Mice; Mice, Nude; Neuroblastoma; Ornithine Carbamoyltransferase; Receptors, Chimeric Antigen; T-Lymphocytes; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2020 |
Complexation of NAC-Derived Peptide Ligands with the C-Terminus of α-Synuclein Accelerates Its Aggregation.
Topics: alpha-Synuclein; Amino Acid Substitution; Amyloid; Arginine; Cell Line, Tumor; Drug Design; Humans; Hydrophobic and Hydrophilic Interactions; Ligands; Molecular Dynamics Simulation; Neuroblastoma; Nuclear Magnetic Resonance, Biomolecular; Peptide Fragments; Protein Aggregates; Protein Aggregation, Pathological; Protein Domains; Surface Plasmon Resonance | 2018 |
Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in Neuroblastoma.
Topics: Animals; Arginase; Arginine; Cell Line, Tumor; Humans; Interleukin-1beta; Macrophages; MAP Kinase Signaling System; Mice; Mice, Transgenic; Myeloid Cells; Neuroblastoma; Sarcoma, Ewing; Tumor Microenvironment; Tumor Necrosis Factor-alpha | 2019 |
Decoding the substrate supply to human neuronal nitric oxide synthase.
Topics: Arginine; Cell Line; Citrulline; Enzyme Activation; Extracellular Space; Humans; Lysosomes; Neuroblastoma; Neurons; Nitric Oxide; Nitric Oxide Synthase Type I; Proteasome Endopeptidase Complex; Proteolysis; Substrate Specificity | 2013 |
Inhibition of PKR protects against tunicamycin-induced apoptosis in neuroblastoma cells.
Topics: Amino Acid Substitution; Antibodies, Monoclonal; Apoptosis; Arginine; Cytoprotection; eIF-2 Kinase; Endoplasmic Reticulum; Enzyme Activation; Humans; Lysine; Mutation, Missense; Neuroblastoma; Tumor Cells, Cultured; Tunicamycin | 2014 |
The phosphorylation of Hsp20 enhances its association with amyloid-β to increase protection against neuronal cell death.
Topics: Amyloid beta-Peptides; Arginine; Cell Death; Cell Line, Tumor; Dose-Response Relationship, Drug; HSP20 Heat-Shock Proteins; Humans; Immunoprecipitation; Magnetic Resonance Spectroscopy; Mutation; Neuroblastoma; Peptide Fragments; Peptide Mapping; Phosphorylation; Time Factors | 2014 |
Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity.
Topics: Animals; Antigens, Neoplasm; Arginase; Arginine; Cell Proliferation; Gangliosides; Humans; Lymphocyte Activation; Membrane Proteins; Mice; Neoplasms, Experimental; Neuroblastoma; Receptors, Antigen, T-Cell; Recombinant Proteins; Tumor Microenvironment | 2015 |
Protein arginine methyltransferase 1 is a novel regulator of MYCN in neuroblastoma.
Topics: Arginine; Brain Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Mutation; N-Myc Proto-Oncogene Protein; Neuroblastoma; Phosphorylation; Prognosis; Proportional Hazards Models; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases; Repressor Proteins; RNA, Small Interfering; Threonine | 2016 |
A disintegrin and metalloproteinase (ADAM)-mediated ectodomain shedding of ADAM10.
Topics: ADAM Proteins; ADAM10 Protein; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Arginine; Cell Line; Disintegrins; Enzyme Inhibitors; Humans; Membrane Proteins; Metalloproteases; Mutation; Neuroblastoma; Peptides; Phosphoinositide Phospholipase C; Protein Structure, Tertiary; Protein Transport; RNA, Small Interfering; Tetradecanoylphorbol Acetate; Transfection | 2009 |
Opposing effects of two tissue transglutaminase protein isoforms in neuroblastoma cell differentiation.
Topics: Arginine; Binding Sites; Cell Differentiation; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression Regulation, Enzymologic; GTP-Binding Proteins; Guanosine Triphosphate; Humans; Immunoblotting; Isoenzymes; Neurites; Neuroblastoma; Protein Binding; Protein Glutamine gamma Glutamyltransferase 2; Proto-Oncogene Proteins c-myc; Retinoids; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Transfection; Transglutaminases; Vasoactive Intestinal Peptide | 2010 |
The human polyoma JC virus agnoprotein acts as a viroporin.
Topics: Arginine; Cell Line, Transformed; Cell Membrane; Cell Membrane Permeability; Endoplasmic Reticulum; HeLa Cells; Humans; Hydrophobic and Hydrophilic Interactions; JC Virus; Kidney; Lysine; Mutagenesis; Neuroblastoma; Polyomavirus Infections; Porins; Protein Structure, Tertiary; Tumor Virus Infections; Viral Regulatory and Accessory Proteins; Virulence; Virus Replication | 2010 |
Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy.
Topics: Animals; Apoptosis; Arginine; Benzazepines; Blotting, Western; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neovascularization, Pathologic; Neuroblastoma; Neuropeptide Y; Receptors, Neuropeptide Y; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Xenograft Model Antitumor Assays | 2010 |
Potent amyloidogenicity and pathogenicity of Aβ43.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Arginine; Cell Line, Tumor; Cerebral Cortex; Cognition Disorders; Disease Models, Animal; Embryo, Mammalian; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation; Humans; Immunoprecipitation; Isoleucine; L-Lactate Dehydrogenase; Male; Maze Learning; Memory, Short-Term; Mice; Mice, Inbred C57BL; Mice, Transgenic; Middle Aged; Mutation; Neuroblastoma; Neurons; Peptide Fragments; Presenilin-1 | 2011 |
[³H]UR-MK136: a highly potent and selective radioligand for neuropeptide Y Y₁ receptors.
Topics: Acetylation; Arginine; Cell Line; Diphenylacetic Acids; Guanidine; Humans; Kinetics; Neuroblastoma; Radioligand Assay; Receptors, Neuropeptide Y; Structure-Activity Relationship; Tritium | 2011 |
Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Animals, Newborn; Arginine; Autoradiography; Cell Line, Tumor; Cell Survival; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Enzyme Inhibitors; Female; Functional Laterality; Humans; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuroblastoma; Neurodegenerative Diseases; Neuropeptide Y; Neuroprotective Agents; Nortropanes; Oligopeptides; Oxidopamine; Parkinson Disease; Protein Binding; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Substantia Nigra; Tyrosine 3-Monooxygenase | 2012 |
Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS.
Topics: Arginine; Cell Line, Tumor; DNA, Mitochondrial; Glucose; Glycolysis; Humans; Hybrid Cells; MELAS Syndrome; Mitochondria; Mutation; Neuroblastoma; Neurons; RNA, Transfer, Leu | 2012 |
S-nitrosylated protein disulfide isomerase contributes to mutant SOD1 aggregates in amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Arginine; Biotin; Cell Line, Tumor; Cysteine; Disease Models, Animal; Disease Progression; Humans; Male; Mice; Mice, Transgenic; Mutation; Neuroblastoma; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Protein Disulfide-Isomerases; Protein Folding; S-Nitrosothiols; Spinal Cord; Subcellular Fractions; Superoxide Dismutase; Up-Regulation | 2013 |
Inhibition of thrombin-induced vascular endothelial growth factor production in human neuroblastoma (NB-1) cells by argatroban.
Topics: Animals; Arginine; Calcium; Calcium Signaling; Enzyme Inhibitors; Hemostatics; Humans; Neuroblastoma; PC12 Cells; Phosphatidylinositol 3-Kinases; Pipecolic Acids; Platelet Aggregation Inhibitors; Protein Kinase C; Rats; Sulfonamides; Thrombin; Vascular Endothelial Growth Factor A | 2005 |
A novel HLA-B*35 (B*3570) allele of a Caucasian family differing with one amino acid mismatch from HLA-B*3503 allele in exon 4.
Topics: Alleles; Amino Acid Substitution; Arginine; Base Sequence; Child; Codon; Exons; Family; Female; Haplotypes; HLA-B Antigens; Humans; Molecular Sequence Data; Neuroblastoma; Point Mutation; Sequence Analysis, DNA; White People | 2007 |
Prolyl endopeptidase is revealed following SILAC analysis to be a novel mediator of human microglial and THP-1 cell neurotoxicity.
Topics: Analysis of Variance; Arginine; Carbon Isotopes; Cell Line; Computational Biology; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Humans; Interferon-gamma; L-Lactate Dehydrogenase; Lipopolysaccharides; Mass Spectrometry; Microglia; Monocytes; Neuroblastoma; Neurotoxins; Prolyl Oligopeptidases; Serine Endopeptidases; Tetrazolium Salts; Thiazoles | 2008 |
L-Arginine identified as an endogenous activator for soluble guanylate cyclase from neuroblastoma cells.
Topics: Animals; Arginine; Brain Chemistry; Cell Line; Enzyme Activation; Guanylate Cyclase; Kinetics; Magnetic Resonance Spectroscopy; Mice; Neuroblastoma; Oligopeptides; Peptides; Rats | 1982 |
Thrombin stimulation of guanosine 3',5'-monophosphate formation in murine neuroblastoma cells (clone N1E-115).
Topics: Animals; Arginine; Blood Platelets; Catechols; Clone Cells; Cyclic GMP; Dansyl Compounds; Hirudins; Indomethacin; Masoprocol; Mice; Neuroblastoma; Thrombin; Trypsin | 1983 |
Tumor cell proteinase visualization and quantification using a fluorescent transition-state analog probe.
Topics: Arginine; Dansyl Compounds; Endopeptidases; Fibrosarcoma; Fluorescent Dyes; Histocytochemistry; Humans; Kinetics; Microscopy, Fluorescence; Neuroblastoma; Spectrometry, Fluorescence | 1984 |
Tumor necrosis factor-alpha (TNF-alpha), interferon-gamma, and interleukin-6 but not TNF-beta induce differentiation of neuroblastoma cells: the role of nitric oxide.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Cell Differentiation; DNA; Interferon-gamma; Interleukin-6; Lymphotoxin-alpha; Mice; Neuroblastoma; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Recombinant Proteins; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1994 |
Characterization of platelet activity in neuroblastoma.
Topics: Antithrombins; Arginine; Child, Preschool; Female; Humans; Iloprost; Infant; Infant, Newborn; Kidney Neoplasms; Male; Neuroblastoma; Pheochromocytoma; Pipecolic Acids; Platelet Aggregation; Sulfonamides; Tissue Extracts; Wilms Tumor | 1994 |
Inhibition of neuronal nitric oxide synthase by antipsychotic drugs.
Topics: Amino Acid Oxidoreductases; Animals; Antipsychotic Agents; Arginine; Brain Neoplasms; Calmodulin; Cerebellum; Citrulline; Cyclic GMP; Cytosol; In Vitro Techniques; Male; Mice; Neuroblastoma; Neurons; Nitric Oxide Synthase; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured | 1994 |
Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226.
Topics: Adipocytes; Amino Acid Sequence; Animals; Arginine; Brain; Calcium; CHO Cells; Cricetinae; Dogs; Humans; Kidney; Male; Molecular Sequence Data; Neuroblastoma; Neuropeptide Y; Peptide Fragments; Rabbits; Rats; Receptors, Neuropeptide Y; Stereoisomerism; Substrate Specificity; Tumor Cells, Cultured | 1995 |
Labeling of neuropeptide Y receptors in SK-N-MC cells using the novel, nonpeptide Y1 receptor-selective antagonist [3H]BIBP3226.
Topics: Arginine; Binding, Competitive; Cell Count; Humans; Kinetics; Neuroblastoma; Radioligand Assay; Receptors, Neuropeptide Y; Tritium; Tumor Cells, Cultured | 1995 |
N-methyl-D-aspartate-induced excessive formation of nitric oxide in CHP100 neuroblastoma cells produces death of BMEL melanoma cells in co-culture.
Topics: Arginine; Cell Death; Dizocilpine Maleate; Histocytochemistry; Humans; Melanoma, Experimental; N-Methylaspartate; NADPH Dehydrogenase; Neuroblastoma; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Tumor Cells, Cultured | 1994 |
Inhibition by lithium of cyclic GMP formation without inhibition of nitric oxide generation in the mouse neuroblastoma cell (N1E-115).
Topics: Animals; Arginine; Brain Neoplasms; Carbachol; Cyclic GMP; Guanylate Cyclase; Lithium; Mice; Muscarinic Antagonists; Neuroblastoma; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Tumor Cells, Cultured | 1994 |
The calmodulin antagonist calmidazolium stimulates release of nitric oxide in neuroblastoma N1E-115 cells.
Topics: Animals; Arginine; Calmodulin; Cyclic GMP; Dose-Response Relationship, Drug; Hemoglobins; Imidazoles; Kinetics; Mice; Neuroblastoma; Nitric Oxide; omega-N-Methylarginine; Tumor Cells, Cultured | 1993 |
Death of cultured human neuroblastoma cells induced by HIV-1 gp120 is prevented by NMDA receptor antagonists and inhibitors of nitric oxide and cyclooxygenase.
Topics: Antineoplastic Agents; Arginine; Cell Death; Cyclooxygenase Inhibitors; Flufenamic Acid; HIV Envelope Protein gp120; Humans; Indomethacin; Neuroblastoma; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Prostaglandins; Receptors, N-Methyl-D-Aspartate; Recombinant Proteins; Tumor Cells, Cultured | 1995 |
Leucine 18, a hydrophobic residue essential for high affinity binding of anthopleurin B to the voltage-sensitive sodium channel.
Topics: Amino Acid Sequence; Animals; Arginine; Base Sequence; Binding Sites; Cell Line; DNA Primers; Genes, Synthetic; Intercellular Signaling Peptides and Proteins; Isoleucine; Kinetics; Leucine; Membrane Potentials; Mice; Molecular Sequence Data; Mutagenesis, Site-Directed; Myocardium; Neuroblastoma; Neurons; Peptides; Polymerase Chain Reaction; Rats; Recombinant Proteins; Sea Anemones; Sodium Channels; Structure-Activity Relationship; Transfection; Tumor Cells, Cultured; Veratridine | 1996 |
Arginine-modulated receptor-activated calcium influx via a NO/cyclic GMP pathway in human SK-N-SH neuroblastoma cells.
Topics: Arginine; Calcium; Carbachol; Cyclic GMP; Diffusion; Humans; Intracellular Membranes; Muscarinic Agonists; Neuroblastoma; Nitric Oxide; Osmolar Concentration; Receptors, Muscarinic; Tumor Cells, Cultured | 1997 |
Up-regulation of the neuronal form of nitric oxide synthase in response to prolonged muscarinic M1 receptor stimulation.
Topics: Animals; Arginine; Binding, Competitive; Calcium; Carbachol; CHO Cells; Citrulline; Cricetinae; Dose-Response Relationship, Drug; Humans; Ionomycin; Ionophores; Muscarinic Agonists; Nerve Tissue Proteins; Neuroblastoma; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Receptor, Muscarinic M1; Receptors, Muscarinic; Tritium; Tumor Cells, Cultured | 1998 |
High concentration of L-arginine suppresses nitric oxide synthase activity and produces reactive oxygen species in NB9 human neuroblastoma cells.
Topics: Arginine; Citrulline; DNA Damage; Enzyme Inhibitors; Humans; Kinetics; Neuroblastoma; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Reactive Oxygen Species; RNA, Messenger; Transcription Factor AP-1; Transcriptional Activation; Tumor Cells, Cultured | 1998 |
Role of nitric oxide in ethanol-induced up-regulation of muscarinic acetylcholine receptors in SH-SY5Y cells.
Topics: Arginine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ethanol; Humans; Kinetics; Neuroblastoma; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Receptors, Muscarinic; Tumor Cells, Cultured; Up-Regulation | 2001 |
Evidence that CHP100 neuroblastoma cell death induced by N-methyl-D-aspartate involves L-arginine-nitric oxide pathway activation.
Topics: Amino Acid Oxidoreductases; Arginine; Biotransformation; Brain Neoplasms; Cell Death; Dizocilpine Maleate; Humans; N-Methylaspartate; Neuroblastoma; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Tumor Cells, Cultured | 1992 |
Enhancement of interleukin-2 immunotherapy with L-arginine.
Topics: Amino Acids; Animals; Arginine; Chi-Square Distribution; Cytotoxicity, Immunologic; Drug Synergism; Interleukin-2; Killer Cells, Lymphokine-Activated; Lymphocyte Activation; Male; Mice; Mice, Inbred A; Mice, Inbred BALB C; Neuroblastoma; Random Allocation; Tumor Cells, Cultured | 1992 |
N-hydroxylamine is not an intermediate in the conversion of L-arginine to an activator of soluble guanylate cyclase in neuroblastoma N1E-115 cells.
Topics: Animals; Arginine; Calcium; Cell Line; Cyclic GMP; Cytosol; Guanylate Cyclase; Hydroxylamine; Hydroxylamines; Kinetics; Mice; Neuroblastoma | 1991 |
Activation of cyclic GMP formation in mouse neuroblastoma cells by a labile nitroxyl radical. An electron paramagnetic resonance/spin trapping study.
Topics: Animals; Arginine; Benzenesulfonates; Cyclic AMP; Electron Spin Resonance Spectroscopy; Enzyme Activation; Ferricyanides; Free Radicals; Guanylate Cyclase; Methylene Blue; Mice; NADP; Neuroblastoma; Nitrogen Oxides; Nitroso Compounds; omega-N-Methylarginine; Receptors, Muscarinic; Tumor Cells, Cultured | 1991 |
Effects of arginine derivatives on soluble guanylate cyclase from neuroblastoma N1E 115 cells.
Topics: Arginine; Binding, Competitive; Dansyl Compounds; Guanosine Triphosphate; Guanylate Cyclase; Magnesium; Molecular Structure; Neuroblastoma; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Receptor-mediated generation of an EDRF-like intermediate in a neuronal cell line detected by spin trapping techniques.
Topics: Animals; Arginine; Benzenesulfonates; Carbachol; Electron Spin Resonance Spectroscopy; Enzyme Activation; Free Radicals; Guanylate Cyclase; Mice; Neuroblastoma; Nitric Oxide; Nitrogen Oxides; Nitroso Compounds; Receptors, Muscarinic; Spin Labels; Tumor Cells, Cultured | 1990 |
EDRF release is a common pathway in the activation of guanylate cyclase by receptor agonists and calcium ionophores.
Topics: Arginine; Calcimycin; Calcium; Carbachol; Cells, Cultured; Cyclic GMP; Enzyme Activation; Guanylate Cyclase; Ionophores; Neuroblastoma; Nitric Oxide; omega-N-Methylarginine; Tumor Cells, Cultured | 1990 |
Production of an EDRF-like activity in the cytosol of N1E-115 neuroblastoma cells.
Topics: Animals; Arginine; Cell-Free System; Cyclic GMP; Cytosol; Kinetics; Mice; Neuroblastoma; Nitric Oxide; Nitroarginine; omega-N-Methylarginine; Tumor Cells, Cultured | 1990 |
Selective blockade of receptor-mediated cyclic GMP formation in N1E-115 neuroblastoma cells by an inhibitor of nitric oxide synthesis.
Topics: Animals; Arginine; Bradykinin; Carbachol; Cyclic GMP; Histamine; Mice; Neuroblastoma; Neurotensin; Nitric Oxide; omega-N-Methylarginine; Phosphatidylinositols; Receptors, Drug; Tumor Cells, Cultured | 1990 |
Immunologic effects of arginine supplementation in tumor-bearing and non-tumor-bearing hosts.
Topics: Animals; Arginine; Cytotoxicity, Immunologic; Diet; Dose-Response Relationship, Drug; Glycine; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Lymphocyte Activation; Lymphoma; Macrophages; Male; Mice; Mice, Inbred Strains; Neuroblastoma | 1990 |
The cytosol of N1E-115 neuroblastoma cells synthesizes an EDRF-like substance that relaxes rabbit aorta.
Topics: Animals; Aorta, Thoracic; Arginine; Cytosol; Female; In Vitro Techniques; Muscle Relaxation; Muscle, Smooth, Vascular; Neuroblastoma; Nitric Oxide; Nitroarginine; omega-N-Methylarginine; Rabbits; Superoxide Dismutase; Tumor Cells, Cultured | 1989 |
Arginine, protein malnutrition, and cancer.
Topics: Animals; Arginine; Body Weight; Diet; Glycine; Immune System; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Neoplasm Transplantation; Neuroblastoma; Protein-Energy Malnutrition | 1988 |
Hemophagocytic Lymphohistiocytosis After Initiation of Chemotherapy for Bilateral Adrenal Neuroblastoma.
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Infant; Lymphohistiocytosis, Hemophagocytic; Neuroblastoma; Teniposide; Vincristine | 2016 |
The role of caspases 9 and 9-short (9S) in death ligand- and drug-induced apoptosis in human astrocytoma cells.
Topics: Alternative Splicing; Antineoplastic Agents; Apoptosis; Astrocytoma; Caspase 9; Caspases; Fas Ligand Protein; Humans; Isoenzymes; Ligands; Membrane Glycoproteins; Neuroblastoma; Teniposide; Transgenes; Tumor Cells, Cultured | 2002 |
Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Infant; Italy; Male; Neuroblastoma; Peptichemio; Retrospective Studies; Survival Analysis; Teniposide; Treatment Outcome; Vincristine | 2003 |
[Evaluation of efficacy of treatment for 30 children with neuroblastoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Infant; Male; Neoplasm Staging; Neuroblastoma; Retrospective Studies; Teniposide; Treatment Outcome; Vincristine | 2003 |
Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Humans; Infant; Neoplasm Staging; Neuroblastoma; Prognosis; Teniposide; Vincristine | 1984 |
Clinical evaluation of sequentially scheduled cisplatin and VM26 in neuroblastoma: response and toxicity.
Topics: Bone Marrow; Child; Child, Preschool; Cisplatin; Drug Administration Schedule; Drug Evaluation; Humans; Hypocalcemia; Magnesium; Mitotic Index; Neuroblastoma; Parathyroid Hormone; Podophyllotoxin; Prospective Studies; Teniposide | 1981 |
Autologous bone marrow transplantation for advanced neuroblastoma using teniposide, doxorubicin, melphalan, cisplatin, and total-body irradiation.
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Female; Humans; Infant; Male; Melphalan; Neuroblastoma; Remission Induction; Teniposide; Transplantation, Autologous; Whole-Body Irradiation | 1995 |
"Megatherapy" for advanced neuroblastoma--rationale and role.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Cyclophosphamide; Disease-Free Survival; Drug Resistance; Humans; Melphalan; Neuroblastoma; Prognosis; Teniposide; Vincristine | 1995 |
Teniposide, doxorubicin, melphalan, cisplatin, and total body irradiation with autologous bone marrow transplantation for advanced neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Humans; Infant; Male; Melphalan; Neuroblastoma; Prognosis; Teniposide; Transplantation, Autologous; Whole-Body Irradiation | 1993 |
Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Gene Amplification; Genes, myc; Humans; Infant; Infant, Newborn; Male; Neoplasm Staging; Neuroblastoma; Ploidies; Predictive Value of Tests; Prognosis; Prospective Studies; Survival Analysis; Teniposide; Treatment Outcome | 1997 |
t(3;11) translocation in treatment-related acute myeloid leukemia fuses MLL with the GMPS (GUANOSINE 5' MONOPHOSPHATE SYNTHETASE) gene.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child, Preschool; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 3; Combined Modality Therapy; Cyclophosphamide; DNA, Complementary; DNA, Neoplasm; Doxorubicin; Fatal Outcome; Humans; Leukemia, Myelomonocytic, Acute; Leukemia, Radiation-Induced; Male; Molecular Sequence Data; Myeloid-Lymphoid Leukemia Protein; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neuroblastoma; Oncogene Proteins, Fusion; Polymerase Chain Reaction; Teniposide; Translocation, Genetic; Transplantation Conditioning; Transplantation, Autologous; Vincristine; Whole-Body Irradiation | 2000 |
Epipodophyllotoxin VM-26 in the treatment of childhood neuroblastoma.
Topics: Blood Cells; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infusions, Parenteral; Male; Neuroblastoma; Podophyllotoxin; Teniposide | 1977 |
Treatment of stage IV-S neuroblastoma: a study of 34 cases treated between 1982 and 1987.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Humans; Infant; Infant, Newborn; Liver Neoplasms; Neoplasm Regression, Spontaneous; Neuroblastoma; Prognosis; Remission Induction; Teniposide; Vincristine | 1991 |
Is more better? Dose intensity in neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Neoplasm Staging; Neuroblastoma; Teniposide; Vincristine | 1991 |
VM-26 (teniposide)-induced hypersensitivity and degranulation of basophils in children.
Topics: Adolescent; Allergens; Basophils; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Hypersensitivity; Female; Histamine Release; Humans; Infant; Male; Neuroblastoma; Podophyllotoxin; Polyethylene Glycols; Risk Factors; Teniposide | 1988 |
Bone marrow transplantation for poor prognosis neuroblastoma.
Topics: Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Drug Therapy, Combination; Humans; Melphalan; Neuroblastoma; Prognosis; Teniposide; Transplantation, Homologous | 1988 |
Ifosfamide in previously untreated disseminated neuroblastoma. Results of Study 3A of the European Neuroblastoma Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Cyclophosphamide; Female; Humans; Ifosfamide; Infant; Male; Neuroblastoma; Prospective Studies; Teniposide; Vincristine | 1988 |
[Metastatic neuroblastoma: consolidation treatment with 2 courses of high-dose chemotherapy followed by a bone marrow autograft].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Infant; Male; Melphalan; Neoplasm Staging; Neuroblastoma; Prognosis; Teniposide; Transplantation, Autologous | 1988 |
Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma.
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Transplantation; Carmustine; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Gastrointestinal Diseases; Humans; Infant; Infections; Melphalan; Neuroblastoma; Teniposide; Thoracic Neoplasms; Transplantation, Autologous; Vincristine | 1987 |
Hypersensitivity reactions to teniposide (VM-26): an analysis.
Topics: Adolescent; Adult; Aged; Bibliographies as Topic; Blood Pressure; Brain Neoplasms; Child; Child, Preschool; Data Collection; Drug Evaluation; Drug Hypersensitivity; Edema; Humans; Hypersensitivity, Immediate; Infant; Leukemia; Male; Middle Aged; Neuroblastoma; Podophyllotoxin; Surveys and Questionnaires; Teniposide; Urticaria | 1986 |
Clinical pharmacodynamics of continuous infusion teniposide: systemic exposure as a determinant of response in a phase I trial.
Topics: Child; Drug Administration Schedule; Drug Evaluation; Humans; Infusions, Parenteral; Kinetics; Leukemia; Lymphoma; Neuroblastoma; Podophyllotoxin; Teniposide | 1987 |
[Effectiveness of cis-dichlorodiammine-platinum in the treatment of advanced neuroblastoma].
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Cyclophosphamide; Female; Humans; Male; Neuroblastoma; Teniposide | 1987 |
Allergic reactions to teniposide in patients with neuroblastoma and lymphoid malignancies.
Topics: Child; Child, Preschool; Diphenhydramine; Drug Hypersensitivity; Humans; Leukemia, Lymphoid; Lymphoma; Neuroblastoma; Podophyllotoxin; Teniposide | 1985 |
Treatment of advanced neuroblastoma with two consecutive high-dose chemotherapy regimens and ABMT.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Hematologic Diseases; Humans; Infant; Male; Melphalan; Neuroblastoma; Teniposide | 1985 |
Sequential cis-platinum and VM26 in neuroblastoma: laboratory and clinical (OPEC regimen) studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cells, Cultured; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Drug Synergism; Humans; Infant; Neuroblastoma; Podophyllotoxin; Prognosis; Teniposide; Vincristine | 1985 |